Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Flanders Institute for Biotechnology, Medical Devices Deals, 2012 to YTD 2018 10
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Confo Therapeutics Raises USD7.3 Million Financing 12
Partnerships 14
BioPontis Alliance for Rare Diseases Enters into Co-Development Agreement with VIB 14
ThromboGenics Forms Joint Venture with VIB 15
Licensing Agreements 16
Oncurious Enters into Licensing Agreement with VIB 16
AstraZeneca Enters Into Licensing Agreement with VIB and CD3 17
Equity Offering 18
Aelin Therapeutics Spin Out from K.U. Leuven, University of Leuven and Flanders Institute for Biotechnology 18
Confo Therapeutics Spin Off from VIB and Vrije Universiteit Brussel 19
Acquisition 20
Intrexon Acquires ActoGeniX 20
Flanders Institute for Biotechnology – Key Competitors 22
Flanders Institute for Biotechnology – Key Employees 23
Flanders Institute for Biotechnology – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Jun 02, 2017: New Centre for Bioassay Development and Screening (C-BIOS) launched to support early-stage drug/agro discovery 25
Government and Public Interest 26
Oct 25, 2018: Belgian researchers discover a novel method to block immunosuppression in cancer 26
Aug 30, 2018: Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy 28
Aug 24, 2018: New immunotherapy inhibits tumor growth and protects against metastases 30
Apr 06, 2018: Competitive ERC Advanced Grant awarded to Bart Lambrecht to study the role of protein crystallization in asthma 32
Mar 20, 2018: Two genes cooperate to trigger leukemia development 33
Jul 27, 2017: Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s disease 34
Jun 01, 2017: Scientists give tumor-fighting cells a boost in battling bone marrow 35
May 20, 2017: Wim Versees receives Michael J. Fox Foundation grant for investigating Parkinson’s disease-associated protein 36
May 04, 2017: Crucial role for XBP1 in several aspects of DC functioning and homeostasis 37
May 03, 2017: A new unexpected key player in melanoma development identified 38
Apr 20, 2017: The Baillet Latour Grant 2017 for Medical Research awarded to professor Roosmarijn Vandenbroucke (VIB-UGent) 40
Mar 23, 2017: Competitive ERC Advanced Grant awarded to Peter Carmeliet for Tumor Endothelial Cell research 41
Mar 21, 2017: PHD2 targeting overcomes breast cancer cell death upon glucose starvation 42
Mar 14, 2017: VIB: Three accomplished VIB Scientists receive ERC Consolidator grants 43
Feb 14, 2017: Researchers identify phosphorylation process vital to cancer growth 44
Feb 13, 2017: Scientists isolate new antibodies to fight human respiratory syncytial virus 46
Feb 13, 2017: Scientists isolate new antibodies to fight human respiratory syncytial virus (RSV) 47
Feb 10, 2017: Mitochondrial lipids as potential targets in early onset Parkinson’s disease 49
Product News 50
Aug 22, 2017: BioXp Genomic Workstation Makes European Debut at VIB Research Institute in Belgium 50
Aug 17, 2017: Scientists unravel role of glutamine synthetase in the spread of cancer 51
May 19, 2017: Tau prevents synaptic transmission at early stage of neurodegeneration 52
May 11, 2017: Launch of IMPRiND Consortium to investigate how aggregated proteins contribute to progression of Alzheimer’s and Parkinson’s Disease 53
Jan 20, 2017: Protein IL-33 found to drive allergic sensitivity in the neonatal lung 54
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Key Facts 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flanders Institute for Biotechnology, Deals By Therapy Area, 2012 to YTD 2018 9
Flanders Institute for Biotechnology, Medical Devices Deals, 2012 to YTD 2018 10
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Confo Therapeutics Raises USD7.3 Million Financing 12
BioPontis Alliance for Rare Diseases Enters into Co-Development Agreement with VIB 14
ThromboGenics Forms Joint Venture with VIB 15
Oncurious Enters into Licensing Agreement with VIB 16
AstraZeneca Enters Into Licensing Agreement with VIB and CD3 17
Aelin Therapeutics Spin Out from K.U. Leuven, University of Leuven and Flanders Institute for Biotechnology 18
Confo Therapeutics Spin Off from VIB and Vrije Universiteit Brussel 19
Intrexon Acquires ActoGeniX 20
Flanders Institute for Biotechnology, Key Competitors 22
Flanders Institute for Biotechnology, Key Employees 23
Flanders Institute for Biotechnology, Joint Venture 24
List of Figures
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flanders Institute for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Flanders Institute for Biotechnology, Medical Devices Deals, 2012 to YTD 2018 10